Sitagliptin
Sitagliptin vs. pioglitazone as add-on treatments in patients with uncontrolled type 2 diabetes on the maximal dose of metformin plus sulfonylurea | SpringerLink
DPP-4 Inhibitor | Januvia | Diabetes Medicine
Cardiovascular effects of sitagliptin – An anti‐diabetes medicine - Zhou - 2018 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library
Tolerability Profile of JANUVIA® (sitagliptin) When Added to Metformin vs Metformin Alone
Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome: Trends in Endocrinology & Metabolism
Frontiers | DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications? | Pharmacology
Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study | BMC Endocrine Disorders
Moa of sitagliptin - januvia mechanism trial
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
DPP-4 INHIBITORS - Dipeptidyl peptidase-4 inhibitor - Gliptins - GlobalRPH
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence | Nature Reviews Nephrology
Sitagliptin/Metformin (janumet) as combination therapy in the treatment of type-2 diabetes mellitus. - Abstract - Europe PMC
Sitagliptin - Wikipedia
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
Oral Antidiabetic Agents - ppt download
Continued) Oral diabetes medications: mechanism of action, side effects. | Download Scientific Diagram
Sitagliptin for type 2 diabetes mellitus | DPP 4 inhibitor | Mechanism, precautions & side effects - YouTube
Dipeptidyl peptidase-4 inhibitor Glucagon-like peptide-1 receptor agonist Liraglutide Dulaglutide, others, angle, text, pharmaceutical Drug png | PNGWing
Solved 22. Match the medication with the mechanism of action | Chegg.com
Randomized trial assessing the safety and efficacy of sitagliptin in Chinese patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea alone or combined with metformin - Ba - 2017 - Journal
DPP-4 inhibitors
The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin | Cardiovascular Diabetology | Full Text
Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma‐associated antigen‐A3 expression through Yes‐associated protein inactivation - Wang - 2020 - Cancer Medicine - Wiley Online Library
